|
May 7
|
Rhythm Pharmaceuticals Reports Q1 2024 Results: Revenue Growth Amidst Challenges
|
|
May 7
|
Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
|
|
May 6
|
Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting
|
|
May 1
|
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
|
|
Apr 30
|
Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline
|
|
Apr 29
|
Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology
|
|
Apr 24
|
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
|
|
Apr 14
|
Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
|
|
Apr 10
|
Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?
|
|
Apr 1
|
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
|
|
Mar 25
|
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
|
|
Mar 22
|
Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)
|
|
Mar 20
|
Insider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Shares
|
|
Mar 20
|
Insider Sell: Chief Technical Officer Joseph Shulman Sells 15,515 Shares of Rhythm ...
|
|
Mar 20
|
Insider Sell: CFO Hunter Smith Sells 15,515 Shares of Rhythm Pharmaceuticals Inc (RYTM)
|
|
Mar 6
|
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences
|
|
Dec 30
|
Insider Sell: Rhythm Pharmaceuticals CTO Joseph Shulman Sells 12,941 Shares
|
|
Dec 8
|
Insider Sell Alert: CFO Hunter Smith Sells 27,026 Shares of Rhythm Pharmaceuticals Inc (RYTM)
|
|
Dec 6
|
Rhythm Pharmaceuticals Announces Updates on MC4R Pathway Programs at R&D Event
|
|
Nov 7
|
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates
|